Objectives: The aim of the study was to evaluate differences in immunovirological response to combination antiretroviral therapy (cART) in migrant and native men and women within a European collaboration of HIV cohorts Collaboration of Observational HIV Epidemiological Research in Europ (COHERE) in EuroCoord, 2004–2013. Methods: Migrants were defined as those with geographical origin (GO) different from the reporting country and were grouped as originating from Western Europe and Western Countries (WEWC), Eastern Europe (EE), North Africa and the Middle East (NAME), sub-Saharan Africa (SSA), Latin America (LA), Caribbean (CRB) and Asia/Oceania (ASIA/OCE). Native (NAT) individuals were defined as those originating from the reporting country. CD4 cell counts were modelled using piecewise linear mixed-effects models with two slopes, whereas models to estimate subdistribution hazard ratios (sHRs) were used for time to virological response (VR) (i.e. time from cART initiation to the first of two successive HIV RNA measurements < 400 HIV-1 RNA copies/ml). Results: Of 32 817 individuals, 25 799 (78.6%) were men. The percentage of migrants was higher in women (48.9%) than in men (21.2%) and migrants from SSA accounted for the largest migrant group (29.9% in men and 63.3% in women). Migrant men and women from SSA started at lower CD4 cell counts than NAT individuals, which remained lower over time. VR was ≥ 85% at 12 months for all groups except CRB women (77.7%). Compared with NAT men and women, lower VR was experienced by NAME [sHR 0.91; 95% confidence interval (CI) 0.86–0.97] and SSA (sHR 0.88; 95% CI 0.82–0.95) men and CRB (sHR 0.77; 85% CI 0.67–0.89) women, respectively. Conclusions: Immunovirological response to cART in Western Europe varies by GO and sex of patients. ART benefits are not equal for all, underlining the point that efforts need to prioritize those most in need.

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? / Monge, S.; Mocroft, A.; Sabin, A.; Touloumi, G.; Sighem, A.; Abgrall, S.; Dray-Spira, R.; Spire, B.; Castagna, A.; Mussini, C.; Zangerle, R.; Hessamfar, M.; Anderson, J.; Hamouda, O.; Ehren, K.; Obel, N.; Kirk, O.; Antinori, A.; Girardi, E.; Saracino, A.; Calmy, A.; Wit, S.; Wittkop, L.; Bucher, C.; Montoliu, A.; Raben, D.; Prins, M.; Meyer, L.; Chene, G.; Burns, F.; Amo, J.; Judd, Ali; Zangerle, Robert; Touloumi, Giota; Warszawski, Josiane; Meyer, Laurence; Dabis, François; Krause, Murielle; Ghosn, Jade; Leport, Catherine; Wittkop, Linda; Reiss, Peter; Wit, Ferdinand; Prins, Maria; Bucher, Heiner; Gibb, Diana; Fätkenheuer, Gerd; Amo, Julia; Obel, Niels; Thorne, Claire; Mocroft, Amanda; Kirk, Ole; Stephan, Christoph; Pérez-Hoyos, Santiago; Bartmeyer, Barbara; Chkhartishvili, Nikoloz; Noguera-Julian, Antoni; Antinori, Andrea; Monforte, Antonella; Brockmeyer, Norbert; Prieto, Luis; Conejo, Pablo; Soriano-Arandes, Antoni; Battegay, Manuel; Kouyos, Roger; Mussini, Cristina; Tookey, Pat; Casabona, Jordi; Miró, Josem; Castagna, Antonella; Konopnick, Deborah; Goetghebuer, Tessa; Sönnerborg, Anders; Torti, Carlo; Sabin, Caroline; Teira, Ramon; Garrido, Myriam; Haerry, David; Wit, Stéphane; Miró, M.; Costagliola, Dominique; d'Arminio-Monforte, Antonella; Raben, Dorthe; Chêne, Geneviève; Barger, Diana; Schwimmer, Christine; Termote, Monique; Campbell, Maria; Frederiksen, Casper M; Friis-Møller, Nina; Kjaer, Jesper; Brandt, Rikke; Berenguer, Juan; Bohlius, Julia; Bouteloup, Vincent; Cozzi-Lepri, Alessandro; Davies, Mary-Anne; Dorrucci, Maria; Dunn, David; Egger, Matthias; Furrer, Hansjakob; Guiguet, Marguerite; Grabar, Sophie; Lambotte, Olivier; Leroy, Valériane; Lodi, Sara; Matheron, Sophie; Miró, Jose; Monge, Susana; Nakagawa, Fumiyo; Paredes, Roger; Phillips, Andrew; Puoti, Massimo; Rohner, Eliane; Schomaker, Michael; Smit, Colette; Sterne, Jonathan; Thiebaut, Rodolphe; Valk, Marc. - In: HIV MEDICINE. - ISSN 1464-2662. - 19:1(2018), pp. 42-48. [10.1111/hiv.12536]

Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

Mussini, Cristina;
2018

Abstract

Objectives: The aim of the study was to evaluate differences in immunovirological response to combination antiretroviral therapy (cART) in migrant and native men and women within a European collaboration of HIV cohorts Collaboration of Observational HIV Epidemiological Research in Europ (COHERE) in EuroCoord, 2004–2013. Methods: Migrants were defined as those with geographical origin (GO) different from the reporting country and were grouped as originating from Western Europe and Western Countries (WEWC), Eastern Europe (EE), North Africa and the Middle East (NAME), sub-Saharan Africa (SSA), Latin America (LA), Caribbean (CRB) and Asia/Oceania (ASIA/OCE). Native (NAT) individuals were defined as those originating from the reporting country. CD4 cell counts were modelled using piecewise linear mixed-effects models with two slopes, whereas models to estimate subdistribution hazard ratios (sHRs) were used for time to virological response (VR) (i.e. time from cART initiation to the first of two successive HIV RNA measurements < 400 HIV-1 RNA copies/ml). Results: Of 32 817 individuals, 25 799 (78.6%) were men. The percentage of migrants was higher in women (48.9%) than in men (21.2%) and migrants from SSA accounted for the largest migrant group (29.9% in men and 63.3% in women). Migrant men and women from SSA started at lower CD4 cell counts than NAT individuals, which remained lower over time. VR was ≥ 85% at 12 months for all groups except CRB women (77.7%). Compared with NAT men and women, lower VR was experienced by NAME [sHR 0.91; 95% confidence interval (CI) 0.86–0.97] and SSA (sHR 0.88; 95% CI 0.82–0.95) men and CRB (sHR 0.77; 85% CI 0.67–0.89) women, respectively. Conclusions: Immunovirological response to cART in Western Europe varies by GO and sex of patients. ART benefits are not equal for all, underlining the point that efforts need to prioritize those most in need.
2018
25-lug-2017
19
1
42
48
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? / Monge, S.; Mocroft, A.; Sabin, A.; Touloumi, G.; Sighem, A.; Abgrall, S.; Dray-Spira, R.; Spire, B.; Castagna, A.; Mussini, C.; Zangerle, R.; Hessamfar, M.; Anderson, J.; Hamouda, O.; Ehren, K.; Obel, N.; Kirk, O.; Antinori, A.; Girardi, E.; Saracino, A.; Calmy, A.; Wit, S.; Wittkop, L.; Bucher, C.; Montoliu, A.; Raben, D.; Prins, M.; Meyer, L.; Chene, G.; Burns, F.; Amo, J.; Judd, Ali; Zangerle, Robert; Touloumi, Giota; Warszawski, Josiane; Meyer, Laurence; Dabis, François; Krause, Murielle; Ghosn, Jade; Leport, Catherine; Wittkop, Linda; Reiss, Peter; Wit, Ferdinand; Prins, Maria; Bucher, Heiner; Gibb, Diana; Fätkenheuer, Gerd; Amo, Julia; Obel, Niels; Thorne, Claire; Mocroft, Amanda; Kirk, Ole; Stephan, Christoph; Pérez-Hoyos, Santiago; Bartmeyer, Barbara; Chkhartishvili, Nikoloz; Noguera-Julian, Antoni; Antinori, Andrea; Monforte, Antonella; Brockmeyer, Norbert; Prieto, Luis; Conejo, Pablo; Soriano-Arandes, Antoni; Battegay, Manuel; Kouyos, Roger; Mussini, Cristina; Tookey, Pat; Casabona, Jordi; Miró, Josem; Castagna, Antonella; Konopnick, Deborah; Goetghebuer, Tessa; Sönnerborg, Anders; Torti, Carlo; Sabin, Caroline; Teira, Ramon; Garrido, Myriam; Haerry, David; Wit, Stéphane; Miró, M.; Costagliola, Dominique; d'Arminio-Monforte, Antonella; Raben, Dorthe; Chêne, Geneviève; Barger, Diana; Schwimmer, Christine; Termote, Monique; Campbell, Maria; Frederiksen, Casper M; Friis-Møller, Nina; Kjaer, Jesper; Brandt, Rikke; Berenguer, Juan; Bohlius, Julia; Bouteloup, Vincent; Cozzi-Lepri, Alessandro; Davies, Mary-Anne; Dorrucci, Maria; Dunn, David; Egger, Matthias; Furrer, Hansjakob; Guiguet, Marguerite; Grabar, Sophie; Lambotte, Olivier; Leroy, Valériane; Lodi, Sara; Matheron, Sophie; Miró, Jose; Monge, Susana; Nakagawa, Fumiyo; Paredes, Roger; Phillips, Andrew; Puoti, Massimo; Rohner, Eliane; Schomaker, Michael; Smit, Colette; Sterne, Jonathan; Thiebaut, Rodolphe; Valk, Marc. - In: HIV MEDICINE. - ISSN 1464-2662. - 19:1(2018), pp. 42-48. [10.1111/hiv.12536]
Monge, S.; Mocroft, A.; Sabin, A.; Touloumi, G.; Sighem, A.; Abgrall, S.; Dray-Spira, R.; Spire, B.; Castagna, A.; Mussini, C.; Zangerle, R.; Hessamfa...espandi
File in questo prodotto:
File Dimensione Formato  
immunological-and-virological-response-to-antiretroviral-treatme-2017.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 81.95 kB
Formato Adobe PDF
81.95 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1155074
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact